imatinib mesylate has been researched along with Anemia, Hemolytic, Autoimmune in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, S; Li, X; Wang, H; Wang, L; You, Y; Zhang, M; Zhong, Z | 1 |
| Gronkowska, A; Lakomy, M; Michalewska, B; Pogorzala, M; Rokicka, M; Styczynski, J; Tomaszewska, A; Torosian, T; Wiktor-Jedrzejczak, W; Wysocki, M | 1 |
2 other study(ies) available for imatinib mesylate and Anemia, Hemolytic, Autoimmune
| Article | Year |
|---|---|
Role of autoimmune hemolytic anemia as an initial indicator for chronic myeloid leukemia: A case report.
Topics: Adolescent; Anemia, Hemolytic, Autoimmune; Fatal Outcome; Female; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Protein Kinase Inhibitors; Splenectomy | 2020 |
Fatal combined immune hemolytic anemia after double cord blood transplantation in imatinib-resistant CML.
Topics: Anemia, Hemolytic; Anemia, Hemolytic, Autoimmune; Antibodies, Anti-Idiotypic; Antineoplastic Agents; Benzamides; Cord Blood Stem Cell Transplantation; Cyclosporine; Drug Resistance, Neoplasm; Fatal Outcome; Female; Graft vs Host Disease; Humans; Imatinib Mesylate; Immunosuppressive Agents; Leukemia, Myeloid, Chronic-Phase; Piperazines; Pyrimidines; Splenectomy; Transfusion Reaction; Transplantation Conditioning; Young Adult | 2009 |